Implantable Infusion Pumps: World Market Analysis, Forecasts to 2018

 
   Single User - $499
   Site License (one location, 10 users) - $750
   Corporate License - $1,000



Loading...
Published Feb 26, 2015 | 19 Pages | Pub ID: KLI5476346

Implantable Infusion Pumps: World Market Analysis

Implantable infusion pumps are designed to provide long-term drug infusion through intra-arterial, intravenou, subcutaneous, and epidural methods. They difficult to operate and least common among the infusion pump types. This provides a market opportunity. They are typically labeled for specific drugs, dosages, and routes of administration and require a high level of sophistication in the technology to run these pumps.

For this reason market for implantable infusion pumps is limited to a handful of providers. The companies profiled in the report are:

Medtronic
Flowonix Medical, Inc.
Codman & Shurtleff
I-Flow / Halyard Health

Implantable Infusion Pumps: World Market Analysis analyzes the current and potential world market for implantable infusion pumps, with market forecasts to 2018.Estimates are based on a combination of the estimated number of users worldwide and sales from competitors' business segments offering these pumps. The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.

Implantable infusion pumps are most commonly used to administer:

Chronic Pain Medications
Chemotherapy
Anti-spasmodics

The report includes discussion of: Key products, manufacturers and recent developments, including MRI compatibility, Safety issues as well as market analysis


In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times